Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review
- PMID: 23592710
- DOI: 10.1136/annrheumdis-2013-203284
Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review
Abstract
Background: The 2010 ACR/EULAR classification criteria for rheumatoid arthritis (RA) were developed to improve the identification of individuals for studies of RA. We aimed to summarise the performance of the criteria based on the published literature.
Methods: We performed a systematic literature search to identify all studies investigating the 2010 criteria and reporting data allowing to calculate sensitivity (SENS), specificity (SPEC), and positive and negative predictive values. Where possible, meta-analysis was performed.
Results: Seventeen full articles (total 6816 patients) and 17 meeting abstracts (total 4004 patients) fulfilled the inclusion criteria. Pooled sensitivity and specificity for RA (defined by different reference standards) were 0.82 (95% CI 0.79-0.84) and 0.61 (0.59-0.64). Results were comparable for different reference standards: for initiation of methotrexate pooled sensitivity was 0.85 (0.83-0.86) and specificity was 0.52 (0.49-0.54); for initiation of any disease modifying antirheumatic drug they were 0.80 (0.79-0.82) and 0.65 (0.61-0.68), respectively; and for expert opinion 0.88 (0.86-0.90) and 0.48 (0.35-0.52). No differences were observed for use of different types of joint counts. Eight studies and five meeting abstracts directly compared 1987 and 2010 criteria using different reference standards within different target populations showing higher overall sensitivity (+0.11 compared with 1987 criteria) at the cost of lower overall specificity (-0.04).
Conclusions: Two years after their publication, the 2010 ACR/EULAR criteria have been widely tested in the community. They are sensitive to detect cases of RA among various target populations, independent of how the latter is referenced.
Keywords: Early Rheumatoid Arthritis; Epidemiology; Rheumatoid Arthritis.
Similar articles
-
Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA.Best Pract Res Clin Rheumatol. 2013 Aug;27(4):451-66. doi: 10.1016/j.berh.2013.09.001. Epub 2013 Oct 1. Best Pract Res Clin Rheumatol. 2013. PMID: 24315048 Review.
-
Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study.Scand J Rheumatol. 2013;42(5):362-8. doi: 10.3109/03009742.2013.776103. Epub 2013 Apr 23. Scand J Rheumatol. 2013. PMID: 23607599
-
Performance of the 2010 classification criteria for rheumatoid arthritis: a systematic literature review and a meta-analysis.PLoS One. 2013;8(2):e56528. doi: 10.1371/journal.pone.0056528. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437156 Free PMC article.
-
Diagnostic accuracy of ACR/EULAR 2010 criteria for rheumatoid arthritis in a 2-year cohort.J Rheumatol. 2011 Jul;38(7):1250-7. doi: 10.3899/jrheum.101227. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572146
-
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350. Health Technol Assess. 2016. PMID: 27140438 Free PMC article. Review.
Cited by
-
Infiltrations of plasma cells in synovium predict inadequate response to Adalimumab in Rheumatoid Arthritis patients.Arthritis Res Ther. 2024 Oct 31;26(1):186. doi: 10.1186/s13075-024-03426-2. Arthritis Res Ther. 2024. PMID: 39482773 Free PMC article.
-
Immunophenotypic Landscape of synovial tissue in rheumatoid arthritis: Insights from ACPA status.Heliyon. 2024 Jul 4;10(13):e34088. doi: 10.1016/j.heliyon.2024.e34088. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055820 Free PMC article.
-
Gut microbiome-immune interactions and their role in rheumatoid arthritis development.PeerJ. 2024 Jul 11;12:e17477. doi: 10.7717/peerj.17477. eCollection 2024. PeerJ. 2024. PMID: 39006008 Free PMC article.
-
Classification of rheumatoid arthritis: is it time to revise the criteria?RMD Open. 2024 Apr 19;10(2):e003851. doi: 10.1136/rmdopen-2023-003851. RMD Open. 2024. PMID: 38642926 Free PMC article.
-
Clinical effects of HBV infection on patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus.Pak J Med Sci. 2023 Sep-Oct;39(5):1446-1450. doi: 10.12669/pjms.39.5.7232. Pak J Med Sci. 2023. PMID: 37680831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical